FTM

First Turn Management Portfolio holdings

AUM $666M
1-Year Est. Return 86.8%
This Quarter Est. Return
1 Year Est. Return
+86.8%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$666M
AUM Growth
+$130M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
42
New
Increased
Reduced
Closed

Top Buys

1
+$35.8M
2
+$25.5M
3
+$24.8M
4
KYMR icon
Kymera Therapeutics
KYMR
+$15.7M
5
ROIV icon
Roivant Sciences
ROIV
+$14.5M

Top Sells

1
+$29.3M
2
+$17.6M
3
+$16.2M
4
TGTX icon
TG Therapeutics
TGTX
+$16.1M
5
GH icon
Guardant Health
GH
+$15.7M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADMA icon
26
ADMA Biologics
ADMA
$4.12B
$11.9M 1.78%
808,673
-283,688
VERA icon
27
Vera Therapeutics
VERA
$3.3B
$10.3M 1.55%
354,529
+44,863
HROW icon
28
Harrow
HROW
$1.77B
$7.72M 1.16%
160,234
-68,527
MLTX icon
29
MoonLake Immunotherapeutics
MLTX
$1.19B
$1.88M 0.28%
+262,643
HQY icon
30
HealthEquity
HQY
$7.29B
– –
-80,880
ISRG icon
31
Intuitive Surgical
ISRG
$190B
– –
-32,305
KALV icon
32
KalVista Pharmaceuticals
KALV
$738M
– –
-214,138
PODD icon
33
Insulet
PODD
$20.2B
– –
-51,408
RDNT icon
34
RadNet
RDNT
$5.49B
– –
-197,759
SLNO icon
35
Soleno Therapeutics
SLNO
$2.28B
– –
-86,332
SPRY icon
36
ARS Pharmaceuticals
SPRY
$1.05B
– –
-455,953
TGTX icon
37
TG Therapeutics
TGTX
$4.85B
– –
-447,884
VRNA
38
DELISTED
Verona Pharma
VRNA
– –
-309,988
BBNX
39
Beta Bionics
BBNX
$814M
– –
-157,194
ALNY icon
40
Alnylam Pharmaceuticals
ALNY
$47.5B
– –
-17,879
BSX icon
41
Boston Scientific
BSX
$131B
– –
-138,834
GH icon
42
Guardant Health
GH
$14.6B
– –
-302,307
1
2